Pfizer's Stem Cell Research Policy
When people think of human embryonic stem cells, they don't often imagine the power of these cells in drug discovery.
For more than a decade, Pfizer has been using animal or adult stem cells in its laboratories to help screen new compounds and identify safer and more effective medicines.
With compelling evidence from this research, Pfizer has begun to explore accessing drug development technology from leading academic, biotechnology or pharmaceutical partners around the world, who also have experience with currently-available, human embryonic stem cell lines that meet the highest ethical standards set by leading scientific authorities. This Pfizer Stem Cell Policy guides the company's research activities and its exploration of new external partnerships.
The Healthier World podcast series explores issues of global health. Each episode is approximately 2 minutes.
Copyright © 2002-2008 Pfizer Inc. All rights reserved. This information is intended only for residents of the United States.
Business to Business
Careers
Contact Us
Health Care Professionals
Pfizer Global Sites
Privacy Policy
Sitemap
Terms of Use
The product information provided in this site is intended only for residents of the United States.
The products discussed herein may have different product labeling in different countries.
Pfizer Inc is a pharmaceutical company committed to helping people improve their health by discovering and developing medicines.